血液透析と腹膜透析市場-世界の産業規模、動向、機会、予測、タイプ別、製品別、エンドユーザー別、地域別、競合別、2019～2029年

血液透析と腹膜透析の世界市場規模は、2023年に770億8,000万米ドルとなり、2029年までのCAGRは6.45%で、予測期間中に力強い成長が予測されています。

腎代替療法、特に血液透析と腹膜透析の世界市場は、末期腎不全（ESRD）の有病率の増加と世界の高齢化人口の拡大により、大幅な成長を遂げています。これらの高度な医療介入は腎不全を管理する上で重要な要素となっており、腎機能障害に苦しむ患者に命綱を提供しています。広く採用されている血液透析は、透析器を用いて患者の血液を濾過・浄化するものです。このプロセスは通常、透析センターや病院などの専門医療施設で実施されます。血液透析市場は、慢性腎臓病（CKD）、糖尿病、高血圧の罹患率の上昇により、需要が急増しています。各国政府や医療機関は、血液透析件数の増加に対応するためのインフラ整備に投資しており、市場の成長に寄与しています。一方、腹膜透析は自宅で実施可能な代替腎代替療法であり、患者に高い柔軟性と独立性を記載しています。この方法は、腹腔を覆う天然の膜である腹膜を老廃物除去のフィルターとして利用します。腹膜透析市場は、医療施設までの移動時間の短縮、食事制限の少なさ、循環器系への影響の少なさなどの利点により、牽引力を増しています。その結果、患者にとっても医療プロバイダーにとっても、腹膜透析はますます魅力的な選択肢となりつつあります。血液透析と腹膜透析の市場力学は、技術の進歩、償還政策、腎疾患に対する意識の高まりなどの要因に影響されています。透析装置、透析液に使用される材料、遠隔監視システムにおける技術革新は、これらの療法の効率と効果を高めています。さらに、人工知能とデータ分析の統合は、患者の転帰を改善し、治療計画を最適化する上で重要な役割を果たしています。

償還政策と医療資金調達の仕組みは、透析サービスへのアクセスに大きく影響します。政府と民間保険会社は、腎代替療法の需要拡大を支えるため、持続可能な償還の枠組みの確立に取り組んでいます。これは市場に直接的な影響を与え、血液透析と腹膜透析の両方の導入率に影響を与えています。医療の進歩や償還戦略に加えて、啓発キャンペーンや教育イニシアティブも市場成長を促進する重要な要素です。公開会社、非営利団体、製薬会社は、腎臓病のリスク、予防、管理について医療従事者と一般市民の双方を教育するプログラムに投資しています。こうした意識の高まりは、早期発見、タイムリーな介入、血液透析と腹膜透析市場全体の成長に寄与しています。

血液透析と腹膜透析市場の競合情勢は、Fresenius Medical Care、Baxter International、DaVita Inc.などの主要参入企業やその他の中東・アフリカ参入企業の存在によって特徴付けられます。これらの企業は、市場での地位を維持し、製品ポートフォリオを拡大するために、戦略的提携、合併・買収、継続的研究開発に取り組んでいます。結論として、血液透析と腹膜透析の世界市場は、腎疾患の有病率の増加、技術の進歩、有利な償還政策、意識の高まりによって力強い成長を遂げています。腎代替療法の需要が増加し続ける中、業界はさらなる革新と拡大を遂げ、世界中の患者が末期腎疾患に対する効果的かつ先進的な治療法を利用できるように態勢を整えています。

主要市場の促進要因

慢性腎臓病の有病率の上昇

需要増に寄与する高齢化

主要市場課題

移植に利用できる臓器が限られている

高い治療費と患者の経済的負担

腹膜透析に伴う感染リスク

アクセシビリティに影響する技術的障壁

主要市場動向

治療効果を高める技術の進歩

在宅腹膜透析の重視の高まり

個別化医療と精密医療への注目の高まり

透析管理における人工知能の統合

セグメント別洞察

タイプ別洞察

製品別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の血液透析と腹膜透析市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • タイプ別（血液透析、腹膜透析）
  • 製品別（デバイス、消耗品、サービス）
  • エンドユーザー別（在宅、病院）
  • 地域別
  • 企業別（2023年）
• 市場マップ
  • タイプ別
  • 製品別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋の血液透析と腹膜透析市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • タイプ別
  • 製品別
  • エンドユーザー別
  • 国別
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の血液透析と腹膜透析市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • タイプ別
  • 製品別
  • エンドユーザー別
  • 国別
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の血液透析と腹膜透析市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • タイプ別
  • 製品別
  • エンドユーザー別
  • 国別
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の血液透析と腹膜透析市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • タイプ別
  • 製品別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの血液透析と腹膜透析市場展望

• 市場規模予測
  • 金額別
• 市場シェア予測
  • タイプ別
  • 製品別
  • エンドユーザー別
  • 国別
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と新興国市場開拓

• 製品発表
• 合併・買収

第12章 血液透析と腹膜透析の世界市場のSWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Baxter International Inc
• B. Braun Melsungen AG
• Fresenius Medical Care AG
• Medtronic, Inc
• Asahi Kasei Medical Co., Ltd
• Nipro Corp
• DaVita Inc
• Becton Dickinson Co
• Nikkiso Co., Ltd

第15章 戦略的提言

第16章 戦略的提言当社について免責事項

Global Hemodialysis and Peritoneal Dialysis Market was valued at USD 77.08 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.45% through 2029.The global market for renal replacement therapies, specifically Hemodialysis and Peritoneal Dialysis, is experiencing substantial growth due to the increasing prevalence of end-stage renal disease (ESRD) and the expanding aging population worldwide. These advanced medical interventions have become critical components in managing renal failure, providing a lifeline for patients suffering from impaired kidney function. Hemodialysis, a widely adopted procedure, involves the use of a dialysis machine to filter and purify the patient's blood. This process is typically conducted in specialized healthcare facilities such as dialysis centers or hospitals. The market for hemodialysis is witnessing a surge in demand owing to the rising incidence of chronic kidney diseases (CKD), diabetes, and hypertension. Governments and healthcare organizations globally are investing in infrastructure to support the increasing number of hemodialysis procedures, contributing to the growth of the market. On the other hand, Peritoneal Dialysis offers an alternative renal replacement therapy that can be administered at home, providing patients with greater flexibility and independence. This method utilizes the peritoneum, a natural membrane lining the abdominal cavity, as a filter for waste removal. The Peritoneal Dialysis market is gaining traction due to its advantages, including reduced travel to healthcare facilities, fewer dietary restrictions, and a lower impact on the cardiovascular system. As a result, it is becoming an increasingly attractive option for both patients and healthcare providers. The market dynamics for both Hemodialysis and Peritoneal Dialysis are influenced by factors such as technological advancements, reimbursement policies, and the growing awareness of renal diseases. Technological innovations in dialysis machines, materials used in dialysis solutions, and remote monitoring systems are enhancing the efficiency and effectiveness of these therapies. Moreover, the integration of artificial intelligence and data analytics is playing a crucial role in improving patient outcomes and optimizing treatment plans.

Reimbursement policies and healthcare financing mechanisms significantly impact the accessibility of dialysis services. Governments and private insurers are working to establish sustainable reimbursement frameworks to support the growing demand for renal replacement therapies. This has a direct impact on the market, influencing the adoption rates of both Hemodialysis and Peritoneal Dialysis. In addition to medical advancements and reimbursement strategies, awareness campaigns and educational initiatives are vital components driving market growth. Governments, non-profit organizations, and pharmaceutical companies are investing in programs to educate both healthcare professionals and the general public about the risks, prevention, and management of kidney diseases. This increased awareness contributes to early detection, timely intervention, and the overall growth of the Hemodialysis and Peritoneal Dialysis markets.

The competitive landscape of the Hemodialysis and Peritoneal Dialysis market is characterized by the presence of key players such as Fresenius Medical Care, Baxter International, DaVita Inc., and other regional players. These companies are engaged in strategic collaborations, mergers and acquisitions, and continuous research and development to maintain their market positions and expand their product portfolios. In conclusion, the global market for Hemodialysis and Peritoneal Dialysis is witnessing robust growth driven by the increasing prevalence of renal diseases, technological advancements, favorable reimbursement policies, and heightened awareness. As the demand for renal replacement therapies continues to rise, the industry is poised for further innovation and expansion, ensuring that patients worldwide have access to effective and advanced treatments for end-stage renal disease.

Key Market Drivers

Rising prevalence of chronic kidney diseases

The rising prevalence of chronic kidney diseases (CKD) serves as a significant driver for the growth of the Hemodialysis and Peritoneal Dialysis market. Globally, the incidence of CKD has been steadily increasing, propelled by factors such as sedentary lifestyles, diabetes, hypertension, and an aging population. As CKD progresses to end-stage renal disease (ESRD), patients experience a substantial decline in kidney function, necessitating renal replacement therapies like Hemodialysis and Peritoneal Dialysis. The expanding CKD patient pool directly correlates with an upsurge in demand for dialysis services. Hemodialysis, conducted in specialized centers, and Peritoneal Dialysis, offering home-based alternatives, become indispensable in managing ESRD. The prevalence of risk factors leading to CKD, coupled with limited organ availability for transplantation, further accentuates the reliance on dialysis as a primary treatment modality. The healthcare industry is witnessing concerted efforts to address the escalating CKD burden, with a focus on early detection, intervention, and the provision of effective renal replacement therapies. As a result, the Hemodialysis and Peritoneal Dialysis market is poised to expand in tandem with the growing prevalence of chronic kidney diseases, underscoring the critical role these therapies play in improving patients' quality of life and overall healthcare outcomes.

Aging population contributing to increased demand.

The aging population is a pivotal factor driving the increased demand for Hemodialysis and Peritoneal Dialysis, creating a substantial impact on the global renal replacement therapy market. As individuals age, the risk of developing chronic kidney diseases (CKD) and other renal disorders rises significantly. Age-related physiological changes, combined with a higher prevalence of conditions like diabetes and hypertension, contribute to the progressive decline in kidney function among the elderly. The demographic shift towards an older population is evident worldwide, particularly in developed nations. This demographic transition results in a greater number of individuals at risk of developing end-stage renal disease (ESRD), necessitating regular dialysis for survival. Hemodialysis, conducted in clinical settings, and Peritoneal Dialysis, offering a more flexible home-based approach, become indispensable components in managing the health of elderly patients with compromised renal function. The aging population's impact on the Hemodialysis and Peritoneal Dialysis market is further accentuated by the fact that elderly individuals often present with multiple comorbidities, making them more prone to kidney-related complications. Consequently, the demand for renal replacement therapies is expected to continue rising in tandem with the global demographic shift towards an increasingly older population, underscoring the critical role of dialysis in addressing the healthcare needs of aging individuals with renal impairments.

Key Market Challenges

Limited organ availability for transplantation

Limited organ availability for transplantation poses a significant challenge to the Hemodialysis and Peritoneal Dialysis market. Despite being the preferred long-term solution for end-stage renal disease (ESRD), organ scarcity leads to prolonged waiting times for transplants, leaving a considerable number of patients dependent on dialysis. This constraint intensifies the demand for Hemodialysis and Peritoneal Dialysis, making them crucial lifelines for individuals awaiting transplantation. The challenge underscores the necessity for continued advancements in organ procurement and transplantation, as well as sustained efforts to enhance dialysis efficiency and accessibility for patients facing prolonged waits for suitable organ matches.

High treatment costs and financial burden on patients

High treatment costs and the resultant financial burden on patients represent a formidable challenge for the Hemodialysis and Peritoneal Dialysis market. The expenses associated with dialysis treatments, including equipment, facility fees, and ongoing medical care, can be substantial. This financial strain poses barriers to accessibility, limiting the options for individuals with end-stage renal disease (ESRD). The challenge is particularly pronounced in regions with inadequate healthcare coverage or where out-of-pocket expenses are high. Addressing the economic challenges of dialysis is crucial to ensuring equitable access to these life-sustaining treatments and improving the overall affordability of renal replacement therapies for patients worldwide.

Infection risks associated with peritoneal dialysis.

Infection risks linked to peritoneal dialysis present a notable challenge for the Hemodialysis and Peritoneal Dialysis market. Peritoneal dialysis involves the introduction of a catheter into the abdominal cavity, creating a potential entry point for infections. Peritonitis, a serious complication, can lead to treatment interruptions, hospitalizations, and increased healthcare costs. Mitigating infection risks requires stringent adherence to hygiene protocols, patient education, and continuous monitoring. This challenge emphasizes the need for ongoing advancements in infection prevention strategies and the development of innovative technologies to enhance the safety profile of peritoneal dialysis, ensuring its effectiveness while minimizing associated health risks for patients.

Technological barriers impacting accessibility.

Technological barriers pose a significant challenge to the accessibility of Hemodialysis and Peritoneal Dialysis. Advanced dialysis technologies, while enhancing treatment efficacy, can be cost-prohibitive and complex. In some regions, limited infrastructure and resources hinder the widespread adoption of state-of-the-art dialysis equipment. Additionally, disparities in technological literacy among healthcare professionals and patients further impede accessibility. Overcoming these barriers requires concerted efforts to develop user-friendly and cost-effective technologies, coupled with comprehensive training programs. Addressing technological challenges is vital for ensuring equitable access to high-quality Hemodialysis and Peritoneal Dialysis treatments, particularly in underserved and resource-limited healthcare environments.

Key Market Trends

Technological advancements enhancing treatment efficacy

Technological advancements are steering a transformative trend in the Hemodialysis and Peritoneal Dialysis market by significantly enhancing treatment efficacy. Innovations in dialysis machines, monitoring systems, and bioinformatics are optimizing the precision and efficiency of renal replacement therapies. The integration of smart technologies allows real-time monitoring of patients, facilitating personalized treatment plans and early detection of potential complications. Additionally, improved materials in dialysis solutions contribute to better biocompatibility, reducing adverse reactions. This trend not only elevates the overall patient experience but also underscores the industry's commitment to advancing therapeutic outcomes through cutting-edge technologies, shaping the future landscape of Hemodialysis and Peritoneal Dialysis

Growing emphasis on home-based Peritoneal Dialysis

The Hemodialysis and Peritoneal Dialysis market is witnessing a prominent trend with the growing emphasis on home-based Peritoneal Dialysis (PD). Recognizing the advantages of PD, including increased patient autonomy and reduced healthcare facility visits, there is a notable shift towards promoting and expanding home dialysis programs. This trend is driven by advancements in PD technology, improved patient education, and efforts to enhance infrastructure for home-based treatments. The shift towards home-based Peritoneal Dialysis aligns with the broader healthcare trend of personalized and patient-centric care, offering individuals with end-stage renal disease a convenient and flexible option for managing their condition in the comfort of their homes.

Increasing focus on personalized and precision medicine

A significant trend shaping the Hemodialysis and Peritoneal Dialysis market is the increasing focus on personalized and precision medicine. Advancements in genetic and biomarker research are paving the way for tailored treatment approaches, optimizing therapeutic outcomes for individual patients. The move towards precision medicine involves identifying patient-specific factors, such as genetic predispositions and biomarkers, to customize dialysis regimens. This trend not only enhances treatment efficacy but also minimizes adverse effects, reflecting a paradigm shift towards more targeted and patient-centric care. As the industry integrates these personalized approaches, the Hemodialysis and Peritoneal Dialysis market is poised to provide more effective and individualized renal replacement therapies.

Integration of artificial intelligence in dialysis management

The Hemodialysis and Peritoneal Dialysis market is experiencing a transformative trend with the integration of artificial intelligence (AI) in dialysis management. AI applications are revolutionizing treatment protocols by offering real-time data analytics, predictive modeling, and decision support systems. These technologies enhance treatment precision, optimize resource allocation, and enable early detection of potential complications. AI-driven solutions also facilitate remote patient monitoring, empowering healthcare professionals to deliver proactive and personalized care. The trend towards AI integration represents a significant leap in dialysis management, fostering efficiency, improving patient outcomes, and contributing to the evolution of more sophisticated and data-driven approaches within the Hemodialysis and Peritoneal Dialysis market.

Segmental Insights

Type Insights

Basedon the Type, The dominance of the hemodialysis segment in the Hemodialysis and Peritoneal Dialysis market can be attributed to its established infrastructure and widespread accessibility. Hemodialysis is primarily conducted in specialized centers equipped with advanced technology and skilled healthcare professionals. This centralized approach ensures efficient treatment delivery and comprehensive patient care. Additionally, hemodialysis is often favored for its immediate and intensive blood purification capabilities, making it the preferred choice for patients with more severe renal impairment. While peritoneal dialysis offers home-based alternatives, the infrastructure and expertise required for hemodialysis have contributed to its continued dominance in the renal replacement therapy landscape.

Product Insights

The service segment's dominance in the Hemodialysis and Peritoneal Dialysis market can be attributed to the comprehensive and ongoing nature of renal replacement therapies. While equipment and consumables contribute to the market, services encompass a continuum of care, including skilled medical personnel, infrastructure, and treatment protocols. Dialysis services are critical for patient well-being, requiring constant monitoring, adjustments, and expertise. Moreover, the growing prevalence of end-stage renal disease and the increasing demand for dialysis have elevated the importance of service providers in delivering high-quality, accessible, and continuous care, positioning the service segment as a key driver in the Hemodialysis and Peritoneal Dialysis market.

Regional Insights

North America's dominance in the Hemodialysis and Peritoneal Dialysis market is attributed to advanced healthcare infrastructure, high prevalence of chronic kidney diseases, and favorable reimbursement policies. The region's robust economic landscape facilitates widespread access to costly dialysis treatments. Moreover, a well-established regulatory framework ensures quality standards. Investments in technological advancements and a growing aging population further drive market growth. The presence of key market players and extensive research activities contribute to North America's leadership in providing advanced renal replacement therapies, solidifying its position as a pivotal hub for Hemodialysis and Peritoneal Dialysis market dominance.

Key Market Players

Baxter International Inc

B. Braun Melsungen AG

Fresenius Medical Care AG

Medtronic, Inc

Asahi Kasei Medical Co., Ltd

Nipro Corp

DaVita Inc

Becton Dickinson Co

Nikkiso Co., Ltd

Report Scope:

In this report, the GlobalHemodialysis and Peritoneal DialysisMarket has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hemodialysis and Peritoneal Dialysis Market,By Type:

• Haemodialysis
• Peritoneal Dialysis

Hemodialysis and Peritoneal Dialysis Market,By Product:

• Devices
• Consumables
• Services

Hemodialysis and Peritoneal Dialysis Market,By End user:

• Home-based
• Hospital-based

Hemodialysis and Peritoneal Dialysis Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Hemodialysis and Peritoneal Dialysis Market.

Available Customizations:

Global Hemodialysis and Peritoneal Dialysis market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validation
• 2.7.Assumptions and Limitations

3.Executive Summary

• 3.1.Overview of the Market
• 3.2.Overview of Key Market Segmentations
• 3.3.Overview of Key Market Players
• 3.4.Overview of Key Regions/Countries
• 3.5.Overview of Market Drivers, Challenges, Trends

4.Global Hemodialysis and Peritoneal Dialysis Market Outlook

• 4.1.Market Size Forecast
  • 4.1.1.By Value
• 4.2.Market Share Forecast
  • 4.2.1.By Type (Hemodialysis, Peritoneal Dialysis)
  • 4.2.2.By Product (Devices, Consumables, Services)
  • 4.2.3.By End user (Home-based, Hospital-based)
  • 4.2.4.By Region
  • 4.2.5.By Company (2023)
• 4.3.Market Map
  • 4.3.1.By Type
  • 4.3.2.By Product
  • 4.3.3.By End user
  • 4.3.4.By Region

5.Asia Pacific Hemodialysis and Peritoneal Dialysis Market Outlook

• 5.1.Market Size Forecast
  • 5.1.1.By Value
• 5.2.Market Share Forecast
  • 5.2.1.By Type
  • 5.2.2.By Product
  • 5.2.3.By End user
  • 5.2.4.By Country
• 5.3.Asia Pacific: Country Analysis
  • 5.3.1.China Hemodialysis and Peritoneal Dialysis Market Outlook
    • 5.3.1.1.Market Size Forecast
      • 5.3.1.1.1.By Value
    • 5.3.1.2.Market Share Forecast
      • 5.3.1.2.1.By Type
      • 5.3.1.2.2.By Product
      • 5.3.1.2.3.By End user
  • 5.3.2.India Hemodialysis and Peritoneal Dialysis Market Outlook
    • 5.3.2.1.Market Size Forecast
      • 5.3.2.1.1.By Value
    • 5.3.2.2.Market Share Forecast
      • 5.3.2.2.1.By Type
      • 5.3.2.2.2.By Product
      • 5.3.2.2.3.By End user
  • 5.3.3.Australia Hemodialysis and Peritoneal Dialysis Market Outlook
    • 5.3.3.1.Market Size Forecast
      • 5.3.3.1.1.By Value
    • 5.3.3.2.Market Share Forecast
      • 5.3.3.2.1.By Type
      • 5.3.3.2.2.By Product
      • 5.3.3.2.3.By End user
  • 5.3.4.Japan Hemodialysis and Peritoneal Dialysis Market Outlook
    • 5.3.4.1.Market Size Forecast
      • 5.3.4.1.1.By Value
    • 5.3.4.2.Market Share Forecast
      • 5.3.4.2.1.By Type
      • 5.3.4.2.2.By Product
      • 5.3.4.2.3.By End user
  • 5.3.5.South Korea Hemodialysis and Peritoneal Dialysis Market Outlook
    • 5.3.5.1.Market Size Forecast
      • 5.3.5.1.1.By Value
    • 5.3.5.2.Market Share Forecast
      • 5.3.5.2.1.By Type
      • 5.3.5.2.2.By Product
      • 5.3.5.2.3.By End user

6.Europe Hemodialysis and Peritoneal Dialysis Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value
• 6.2.Market Share Forecast
  • 6.2.1.By Type
  • 6.2.2.By Product
  • 6.2.3.By End user
  • 6.2.4.By Country
• 6.3.Europe: Country Analysis
  • 6.3.1.France Hemodialysis and Peritoneal Dialysis Market Outlook
    • 6.3.1.1.Market Size Forecast
      • 6.3.1.1.1.By Value
    • 6.3.1.2.Market Share Forecast
      • 6.3.1.2.1.By Type
      • 6.3.1.2.2.By Product
      • 6.3.1.2.3.By End user
  • 6.3.2.Germany Hemodialysis and Peritoneal Dialysis Market Outlook
    • 6.3.2.1.Market Size Forecast
      • 6.3.2.1.1.By Value
    • 6.3.2.2.Market Share Forecast
      • 6.3.2.2.1.By Type
      • 6.3.2.2.2.By Product
      • 6.3.2.2.3.By End user
  • 6.3.3.Spain Hemodialysis and Peritoneal Dialysis Market Outlook
    • 6.3.3.1.Market Size Forecast
      • 6.3.3.1.1.By Value
    • 6.3.3.2.Market Share Forecast
      • 6.3.3.2.1.By Type
      • 6.3.3.2.2.By Product
      • 6.3.3.2.3.By End user
  • 6.3.4.Italy Hemodialysis and Peritoneal Dialysis Market Outlook
    • 6.3.4.1.Market Size Forecast
      • 6.3.4.1.1.By Value
    • 6.3.4.2.Market Share Forecast
      • 6.3.4.2.1.By Type
      • 6.3.4.2.2.By Product
      • 6.3.4.2.3.By End user
  • 6.3.5.United Kingdom Hemodialysis and Peritoneal Dialysis Market Outlook
    • 6.3.5.1.Market Size Forecast
      • 6.3.5.1.1.By Value
    • 6.3.5.2.Market Share Forecast
      • 6.3.5.2.1.By Type
      • 6.3.5.2.2.By Product
      • 6.3.5.2.3.By End user

7.North America Hemodialysis and Peritoneal Dialysis Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value
• 7.2.Market Share Forecast
  • 7.2.1.By Type
  • 7.2.2.By Product
  • 7.2.3.By End user
  • 7.2.4.By Country
• 7.3.North America: Country Analysis
  • 7.3.1.United States Hemodialysis and Peritoneal Dialysis Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Type
      • 7.3.1.2.2.By Product
      • 7.3.1.2.3.By End user
  • 7.3.2.Mexico Hemodialysis and Peritoneal Dialysis Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Type
      • 7.3.2.2.2.By Product
      • 7.3.2.2.3.By End user
  • 7.3.3.Canada Hemodialysis and Peritoneal Dialysis Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Type
      • 7.3.3.2.2.By Product
      • 7.3.3.2.3.By End user

8.South America Hemodialysis and Peritoneal Dialysis Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value
• 8.2.Market Share Forecast
  • 8.2.1.By Type
  • 8.2.2.By Product
  • 8.2.3.By End user
  • 8.2.4.By Country
• 8.3.South America: Country Analysis
  • 8.3.1.Brazil Hemodialysis and Peritoneal Dialysis Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Type
      • 8.3.1.2.2.By Product
      • 8.3.1.2.3.By End user
  • 8.3.2.Argentina Hemodialysis and Peritoneal Dialysis Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Type
      • 8.3.2.2.2.By Product
      • 8.3.2.2.3.By End user
  • 8.3.3.Colombia Hemodialysis and Peritoneal Dialysis Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Type
      • 8.3.3.2.2.By Product
      • 8.3.3.2.3.By End user

9.Middle East and Africa Hemodialysis and Peritoneal Dialysis Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value
• 9.2.Market Share Forecast
  • 9.2.1.By Type
  • 9.2.2.By Product
  • 9.2.3.By End user
  • 9.2.4.By Country
• 9.3.MEA: Country Analysis
  • 9.3.1.South Africa Hemodialysis and Peritoneal Dialysis Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Type
      • 9.3.1.2.2.By Product
      • 9.3.1.2.3.By End user
  • 9.3.2.Saudi Arabia Hemodialysis and Peritoneal Dialysis Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Type
      • 9.3.2.2.2.By Product
      • 9.3.2.2.3.By End user
  • 9.3.3.UAE Hemodialysis and Peritoneal Dialysis Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Type
      • 9.3.3.2.2.By Product
      • 9.3.3.2.3.By End user

10.Market Dynamics

• 10.1.Drivers
• 10.2.Challenges

11.Market Trends Developments

• 11.1.Recent Developments
• 11.2.Product Launches
• 11.3.Mergers Acquisitions

12.Global Hemodialysis and Peritoneal Dialysis Market: SWOT Analysis

13.Porter's Five Forces Analysis

• 13.1.Competition in the Industry
• 13.2.Potential of New Entrants
• 13.3.Power of Suppliers
• 13.4.Power of Customers
• 13.5.Threat of Substitute Product

14.Competitive Landscape

• 14.1.Baxter International Inc
  • 14.1.1.Business Overview
  • 14.1.2.Company Snapshot
  • 14.1.3.Product Services
  • 14.1.5.Financials (In case of listed)
  • 14.1.6.Recent Developments
  • 14.1.7.SWOT Analysis
• 14.2.B. Braun Melsungen AG
• 14.3.Fresenius Medical Care AG
• 14.4.Medtronic, Inc
• 14.5.Asahi Kasei Medical Co., Ltd
• 14.6.Nipro Corp
• 14.7.DaVita Inc
• 14.8.Becton Dickinson Co
• 14.9.Nikkiso Co., Ltd

15.Strategic Recommendations

16. About Us Disclaimer